Patents by Inventor Joe Belanoff

Joe Belanoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimizing Mifepristone Absorption
    Publication number: 20220249516
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: April 20, 2022
    Publication date: August 11, 2022
    Applicant: Corcept Therapeutic Inc.
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Optimizing Mifepristone Absorption
    Publication number: 20210046093
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: November 3, 2020
    Publication date: February 18, 2021
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Optimizing mifepristone absorption
    Patent number: 10842801
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: November 24, 2020
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Optimizing Mifepristone Absorption
    Publication number: 20200009159
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 9, 2020
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Optimizing mifepristone absorption
    Patent number: 10500216
    Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: December 10, 2019
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Joe Belanoff, Robert Roe, Caroline Loewy
  • Combination steroid and glucocorticoid receptor antagonist therapy
    Patent number: 8829024
    Abstract: The present invention provides compositions of an anti-inflammatory glucocorticosteroid and a glucocorticoid receptor (GR) modulator useful for inhibiting glucocorticoid receptor induced transactivation without substantially inhibiting glucocorticoid receptor induced transrepression. Also provided are methods of treating a disorder or condition and reducing the side effects of glucocorticosteroid treatment, using the compositions of the present invention.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: September 9, 2014
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Joe Belanoff, Peter Lockey
  • COMBINATION STEROID AND GLUCOCORTICOID RECEPTOR ANTAGONIST THERAPY
    Publication number: 20130012486
    Abstract: The present invention provides compositions of an anti-inflammatory glucocorticosteroid and a glucocorticoid receptor (GR) modulator useful for inhibiting glucocorticoid receptor induced transactivation without substantially inhibiting glucocorticoid receptor induced transrepression. Also provided are methods of treating a disorder or condition and reducing the side effects of glucocorticosteroid treatment, using the compositions of the present invention.
    Type: Application
    Filed: January 6, 2012
    Publication date: January 10, 2013
    Applicant: Corcept Therapeutics, Inc. (019904)
    Inventors: Joe Belanoff, Peter Lockey